OPEN END INDEX-CERTIFICATE - AMGEN | Real-time Euronext Paris 07:19:32 2024-05-20 am EDT | ||
| 1.231 EUR | +0.49% |
|
| Current month | +12.08% | ||
| 1 month | +15.57% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-20 | 1.231 | +0.49% |
| 24-05-17 | 1.225 | -0.81% |
| 24-05-16 | 1.235 | -1.12% |
| 24-05-15 | 1.249 | +2.55% |
| 24-05-14 | 1.218 | +0.16% |
Real-time Euronext Paris
Last update May 20, 2024 at 07:19 am EDT
More quotesStatic data
| Product type | Index- and Participation Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| J833S | |
| ISIN | FRSGE001LLF4 |
| Date issued | 2023-04-27 |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 0.91 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.296 € |
|---|---|
| Lowest since issue | 0.836 € |
| Spread | 0.009 € |
| Spread % | 0.73% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.5
USD
Average target price
314.6
USD
Spread / Average Target
+0.70%
- Stock Market
- Certificates
- J833S Certificat
